Wealthcare Advisory Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
CCA
Wealthcare Advisory Partners's RGEN Position: Q2 2021 in Review
Wealthcare Advisory Partners sold out of Repligen (RGEN) in Q2 2021, closing a stake of 409 shares — an estimated $80K sold.
Wealthcare Advisory Partners first reported a position in RGEN in Q1 2020 and held it in 2 quarters. The position peaked at $80K in Q1 2021. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.
- Wealthcare Advisory Partners reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
- Wealthcare Advisory Partners sold 409 Repligen shares in Q2 2021, an estimated $80K.
- Wealthcare Advisory Partners first reported a position in Repligen in Q1 2020 and held it in 2 quarters.
- Wealthcare Advisory Partners's Repligen position peaked at $80K in Q1 2021.
- 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.